Drugs / Inactivated subvirion H7N9 vaccine
last change May 2016 re-read 3 minutes ago

Inactivated subvirion H7N9 vaccine

Vaccine

Developed for
swine influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 2

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02274545 Oct 2014 → May 2016 swine influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 1 NCT02151344 May 2014 → Feb 2015 swine influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Inactivated subvirion H7N9 vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02274545 ↗
1

NCT02151344 ↗

Modality Vaccine “inactivated subvirion H7N9 vaccine” NCT02151344 ↗